Status
Conditions
Treatments
About
This is a prospective, randomized, controlled study to evaluate the diagnostic yield and safety of three-dimensionally printed navigational template in percutaneous transthoracic lung biopsy.
Full description
The feasibility of three-dimensionally printed navigational template-guided percutaneous transthoracic fine-needle aspiration was validated by a phase I study. To further investigate the non-inferiority of navigational template-guided lung biopsy to conventional CT-guided modality in terms of diagnostic yield, this prospective, randomized, controlled, noninferiority trial was conducted.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Ⅰ. Inclusion Criteria:
A. CT confirmed peripheral lung lesion;
B. Nodule size larger than or equal to 30 mm;
C. Scheduled for percutaneous transthoracic fine-needle aspiration;
D. Percutaneous transthoracic lung biopsy was conducted at supine or partially lateral decubitus;
E. Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2;
F. Written informed consent provided.
Ⅱ. Exclusion Criteria:
A. Biopsy needle insertion route impeded by skeletal structures;
B. Lesion within 3 cm above diaphragmatic dome;
C. Insertion route longer than the biopsy needle;
D. Lung biopsy needed to be conducted at vertically lateral decubitus;
E. Any contraindication of percutaneous transthoracic lung biopsy;
F. Women who are pregnant or in the period of breastfeeding.
Primary purpose
Allocation
Interventional model
Masking
150 participants in 2 patient groups
Loading...
Central trial contact
Haoran E, MD; Chang Chen, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal